Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 526 AL 540

Meta-analysis of the efficacy of interventions for persons living with Alzheimer's disease: The role of music therapy

Zhou C, Ji Y, Wang Y, Liang Y, Cao Y, Lin L, Wang Y, Yang Z, Liu S, Chen H.

J Alzheimers Dis. 2026 May;111(2):505-517. doi: 10.1177/13872877261433196. Epub 2026 Mar 23.

Lecanemab treatment for mild alzheimer's disease with high risk of cerebral hemorrhage: a case report

Tian Q, Liu M, Zhong F, Liu X, Lü Y.

BMC Neurol. 2026 Jan 9;26(1):76. doi: 10.1186/s12883-025-04581-y.

Psychopharmacotherapy of Alzheimer's Disease-What Do We Have at Hand?

Naguy A, Pridmore S, Singh A, Solanki A.

Psychopharmacol Bull. 2026 Mar 11;56(2):170-175. doi: 10.64719/pb.16605.

The Role of Amyloid-β and Tau PET in the New Era of Alzheimer Disease Therapies

Chiotis K, Wang Y, La Joie R, Rabinovici GD.

J Nucl Med. 2026 Feb 2;67(2):175-185. doi: 10.2967/jnumed.124.268339.

Balancing Speed and Sensitivity: Echo-Planar Accelerated MRI for ARIA-H Screening in Anti-Aβ Therapeutics

Hagiwara A.

Invest Radiol. 2026 May 1;61(5):307-308. doi: 10.1097/RLI.0000000000001232.

Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic Model

Bhagunde P, Penner N, Willis BA, Bell R, Charil A, Irizarry MC, Hersch S, Reyderman L.

CPT Pharmacometrics Syst Pharmacol. 2026 Feb;15(2):e70173. doi: 10.1002/psp4.70173.

Theranostic Nanoplatforms for Alzheimer's Disease: A Critical Analysis of Conceptual Contradictions

Zorkina Y, Abramova O, Zubkov E, Gurina O, Ushakova V.

Int J Mol Sci. 2026 Apr 16;27(8):3560. doi: 10.3390/ijms27083560.

Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes

Perry R, Kipps C, Soto Martín ME, Bozzali M, Logroscino G, Trafford S, Dhadda S, Kanekiyo M, Goodwin A, Hodgkinson M, Hersch S, Irizarry M, Kramer L, Froelich L.

J Prev Alzheimers Dis. 2026 Apr;13(4):100507. doi: 10.1016/j.tjpad.2026.100507. Epub 2026 Feb 13.

Predictive Model of Acupuncture Adherence in Alzheimer Disease: Secondary Analysis of Randomized Controlled Trials

Chen ZH, Li R, Jiang YH, He JK, Yan SS, Zong GH, Yi ZX, Ren XY, Jia BH.

JMIR Aging. 2026 Jan 21;9:e82787. doi: 10.2196/82787.

Antibody-based nanoparticles in Alzheimer's disease: Innovations in diagnosis and therapy

Patwekar F, Patwekar M, Wei LS, Sharma R, Varghese R, Mohammed A.

Pathol Res Pract. 2026 May;281:156421. doi: 10.1016/j.prp.2026.156421. Epub 2026 Feb 24.

Alzheimer's disease and related dementias in rural medicare populations: a scoping review

Kianfar N, Alsharayri S, Mollalo A.

BMC Geriatr. 2026 Jan 27;26(1):237. doi: 10.1186/s12877-026-07031-7.

Cognition, Diagnosis, and Treatment of Alzheimer's Disease: A Review

Qin Y, Deng X, Zhang S.

Recent Pat Biotechnol. 2026;20(2):260-280. doi: 10.2174/0118722083358924250606173812.

[Efficacy of choline alfoscerate treatment for subjective cognitive impairment in first-degree relatives of patients with Alzheimer's disease: Results of a comparative 5-year study]

Selezneva ND, Roshchina IF, Gavrilova SI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):92-99. doi: 10.17116/jnevro202612604292.

Examining adverse effects in a large clinical trial of rTMS application as a treatment for Alzheimer's disease

Uehara MA, Bretecher CA, Teschuk JM, Verot A, Saha C, Fitzgerald PB, Koski L, Millikin C, Moussavi Z.

Psychiatry Res. 2026 Aug;362:117212. doi: 10.1016/j.psychres.2026.117212. Epub 2026 May 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias